Related Experiment Video
Updated: Jul 7, 2026

10:23
Time-Resolved Fluorescence Anisotropy from Single Molecules for Characterizing Local Flexibility in Biomolecules
Published on: April 25, 2025
A new optical platform for biosensing based on fluorescence anisotropy
F Baldini1, A Carloni, A Giannetti
1Institute of Applied Physics, CNR, Via Madonna del Piano 10, 50019, Sesto Fiorentino (FI), Italy. f.baldini@ifac.cnr.it
Analytical and Bioanalytical Chemistry
|February 16, 2008
Summary
A new optical biochip platform using poly(methyl methacrylate) (PMMA) was developed for sensitive biosensing. This innovative fluorescence-based system achieved low detection limits for IgG/anti-IgG interactions.
Area of Science:
- Biophotonics
- Materials Science
- Analytical Chemistry
Background:
- Development of sensitive and specific biosensors is crucial for disease diagnosis and monitoring.
- Optical biochips offer advantages in miniaturization and high-throughput analysis.
- Poly(methyl methacrylate) (PMMA) is a suitable material for microfluidic devices due to its optical properties and processability.
Purpose of the Study:
- To design and develop a novel fluorescence-based optical platform for interrogating an optical biochip.
- To investigate the potential of this optical chip as a biosensor for detecting specific biomolecular interactions.
- To optimize surface chemistry for efficient biomolecule immobilization on the PMMA surface.
Main Methods:
- Fabrication of a PMMA-based optical biochip with four microchannels.
- Immobilization of mouse immunoglobulin G (IgG) onto the PMMA surface using various chemical treatments.
- Detection of Cy5-labelled anti-mouse IgG interaction via fluorescence measurements.
- Optimization of PMMA surface functionalization using poly(L-lactic acid), Eudragit L100, and NaOH.
Main Results:
- A functional optical biochip platform was successfully developed using PMMA microchannels.
- Eudragit L100 treatment proved most effective for covalent immobilization of mouse IgG.
- The biosensor achieved a limit of detection (LOD) of 0.05 µg/mL and a limit of quantification (LOQ) of 0.2 µg/mL for IgG/anti-IgG interaction.
Conclusions:
- The developed fluorescence-based optical biochip platform demonstrates high sensitivity and specificity for biosensing applications.
- Optimized surface chemistry is critical for efficient biomolecule immobilization and reliable biosensor performance.
- This PMMA-based optical biochip holds promise for various diagnostic and analytical applications requiring sensitive biomolecule detection.

